Anthony L Guerrerio1, Pamela A Frischmeyer-Guerrerio2, Chengrui Huang3, Yuqiong Wu3, Talin Haritunians4, Dermot P B McGovern4, Gretchen L MacCarrick5, Steven R Brant3, Harry C Dietz5,6. 1. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 2. Division of Intramural Research, NIAID, NIH. 3. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, and Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA. 4. The F.Widjaja Foundation Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 5. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 6. Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Abstract
BACKGROUND: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. METHODS: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. RESULTS: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. CONCLUSION: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.
BACKGROUND: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. METHODS: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. RESULTS: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. CONCLUSION: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.
Authors: Oren Abramson; Michael Durant; William Mow; Allen Finley; Pratima Kodali; Anthony Wong; Venessa Tavares; Erin McCroskey; Liyan Liu; James D Lewis; James E Allison; Nicole Flowers; Susan Hutfless; Fernando S Velayos; Geraldine S Perry; Robert Cannon; Lisa J Herrinton Journal: J Pediatr Date: 2010-04-18 Impact factor: 4.406
Authors: Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz Journal: Nat Genet Date: 2005-01-30 Impact factor: 38.330
Authors: Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz Journal: N Engl J Med Date: 2006-08-24 Impact factor: 91.245
Authors: M T Salmela; S L F Pender; M-L Karjalainen-Lindsberg; P Puolakkainen; T T Macdonald; U Saarialho-Kere Journal: Scand J Gastroenterol Date: 2004-11 Impact factor: 2.423
Authors: Carl A Anderson; Gabrielle Boucher; Charlie W Lees; Andre Franke; Mauro D'Amato; Kent D Taylor; James C Lee; Philippe Goyette; Marcin Imielinski; Anna Latiano; Caroline Lagacé; Regan Scott; Leila Amininejad; Suzannah Bumpstead; Leonard Baidoo; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Jean-Frédéric Colombel; Lee A Denson; Martine De Vos; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Rudolf S N Fehrmann; James A B Floyd; Timothy Florin; Denis Franchimont; Lude Franke; Michel Georges; Jürgen Glas; Nicole L Glazer; Stephen L Guthery; Talin Haritunians; Nicholas K Hayward; Jean-Pierre Hugot; Gilles Jobin; Debby Laukens; Ian Lawrance; Marc Lémann; Arie Levine; Cecile Libioulle; Edouard Louis; Dermot P McGovern; Monica Milla; Grant W Montgomery; Katherine I Morley; Craig Mowat; Aylwin Ng; William Newman; Roel A Ophoff; Laura Papi; Orazio Palmieri; Laurent Peyrin-Biroulet; Julián Panés; Anne Phillips; Natalie J Prescott; Deborah D Proctor; Rebecca Roberts; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Philip Schumm; Frank Seibold; Yashoda Sharma; Lisa A Simms; Mark Seielstad; A Hillary Steinhart; Stephan R Targan; Leonard H van den Berg; Morten Vatn; Hein Verspaget; Thomas Walters; Cisca Wijmenga; David C Wilson; Harm-Jan Westra; Ramnik J Xavier; Zhen Z Zhao; Cyriel Y Ponsioen; Vibeke Andersen; Leif Torkvist; Maria Gazouli; Nicholas P Anagnou; Tom H Karlsen; Limas Kupcinskas; Jurgita Sventoraityte; John C Mansfield; Subra Kugathasan; Mark S Silverberg; Jonas Halfvarson; Jerome I Rotter; Christopher G Mathew; Anne M Griffiths; Richard Gearry; Tariq Ahmad; Steven R Brant; Mathias Chamaillard; Jack Satsangi; Judy H Cho; Stefan Schreiber; Mark J Daly; Jeffrey C Barrett; Miles Parkes; Vito Annese; Hakon Hakonarson; Graham Radford-Smith; Richard H Duerr; Séverine Vermeire; Rinse K Weersma; John D Rioux Journal: Nat Genet Date: 2011-02-06 Impact factor: 38.330
Authors: Aida M Bertoli-Avella; Elisabeth Gillis; Hiroko Morisaki; Judith M A Verhagen; Bianca M de Graaf; Gerarda van de Beek; Elena Gallo; Boudewijn P T Kruithof; Hanka Venselaar; Loretha A Myers; Steven Laga; Alexander J Doyle; Gretchen Oswald; Gert W A van Cappellen; Itaru Yamanaka; Robert M van der Helm; Berna Beverloo; Annelies de Klein; Luba Pardo; Martin Lammens; Christina Evers; Koenraad Devriendt; Michiel Dumoulein; Janneke Timmermans; Hennie T Bruggenwirth; Frans Verheijen; Inez Rodrigus; Gareth Baynam; Marlies Kempers; Johan Saenen; Emeline M Van Craenenbroeck; Kenji Minatoya; Ritsu Matsukawa; Takuro Tsukube; Noriaki Kubo; Robert Hofstra; Marie Jose Goumans; Jos A Bekkers; Jolien W Roos-Hesselink; Ingrid M B H van de Laar; Harry C Dietz; Lut Van Laer; Takayuki Morisaki; Marja W Wessels; Bart L Loeys Journal: J Am Coll Cardiol Date: 2015-04-07 Impact factor: 24.094
Authors: Luc Cozijnsen; Astrid S Plomp; Jan G Post; Gerard Pals; Natalija Bogunovic; Kak K Yeung; Hans W M Niessen; Marie-José T H Goumans; Daniela Q C M Barge-Schaapveld; Dimitra Micha Journal: Mol Genet Genomic Med Date: 2019-09-01 Impact factor: 2.183
Authors: Pamela A Frischmeyer-Guerrerio; Gretchen MacCarrick; Harry C Dietz; F Dylan Stewart; Anthony L Guerrerio Journal: BMC Gastroenterol Date: 2020-03-12 Impact factor: 3.067
Authors: Elena Tosti; Ana S Almeida; Tam T T Tran; Mariel Barbachan E Silva; Pilib Ó Broin; Robert Dubin; Ken Chen; Amanda P Beck; Andrew S Mclellan; Eduardo Vilar; Aaron Golden; Paul W O'Toole; Winfried Edelmann Journal: Cell Mol Gastroenterol Hepatol Date: 2022-06-07
Authors: M Christine Hollander; Lawrence L Latour; Dan Yang; Hiroki Ishii; Zhiguang Xiao; Yongfen Min; Abhik Ray-Choudhury; Jeeva Munasinghe; Anand S Merchant; P Charles Lin; John Hallenbeck; Manfred Boehm; Li Yang Journal: Circ Res Date: 2017-10-19 Impact factor: 17.367